The question to ask is was BVF in a position to participate; the niche biotech funds have almost certainly had to fund significant redemptions over the last couple of years and must have been faced with cashing out positions in the worst of markets?
Ann: ACW Oversubscribed $3.9 million entitlement offer completed, page-12
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1186 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 1015 | 1 |
View Market Depth
| Last trade - 07.04am 04/11/2024 (20 minute delay) ? |
| ACW (ASX) Chart |
Day chart unavailable